Corresponding author at: Department of Pharmacy, 1959 NE Pacific St, Box 357630, Seattle, WA 98195, USA.
was read the article
array:23 [ "pii" => "S2667049621000582" "issn" => "26670496" "doi" => "10.1016/j.neurop.2021.07.004" "estado" => "S300" "fechaPublicacion" => "2022-01-01" "aid" => "41" "copyright" => "Sociedad Española de Neurología" "copyrightAnyo" => "2021" "documento" => "article" "crossmark" => 1 "subdocumento" => "rev" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:17 [ "pii" => "S2667049621000624" "issn" => "26670496" "doi" => "10.1016/j.neurop.2021.07.006" "estado" => "S300" "fechaPublicacion" => "2022-01-01" "aid" => "45" "copyright" => "Sociedad Española de Neurología" "documento" => "article" "crossmark" => 1 "subdocumento" => "rev" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review</span>" "titulo" => "Parkinson's disease: Present and future of cell therapy" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "S58" "paginaFinal" => "S68" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Enfermedad de Parkinson: presente y futuro en los tratamientos con terapia celular" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "F.J. Sancho-Bielsa" "autores" => array:1 [ 0 => array:2 [ "nombre" => "F.J." "apellidos" => "Sancho-Bielsa" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2667049621000624?idApp=UINPBA00004N" "url" => "/26670496/00000002000000S1/v4_202403290506/S2667049621000624/v4_202403290506/en/main.assets" ] "itemAnterior" => array:17 [ "pii" => "S2667049621000806" "issn" => "26670496" "doi" => "10.1016/j.neurop.2021.11.004" "estado" => "S300" "fechaPublicacion" => "2022-01-01" "aid" => "60" "copyright" => "Sociedad Española de Neurología" "documento" => "article" "crossmark" => 1 "subdocumento" => "rev" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review</span>" "titulo" => "Applications of nanomaterials in <span class="elsevierStyleItalic">Neisseria meningitidis</span> infection" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "S43" "paginaFinal" => "S48" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "f0010" "etiqueta" => "Fig. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 2410 "Ancho" => 2819 "Tamanyo" => 402162 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "al0010" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="sp0010" class="elsevierStyleSimplePara elsevierViewall">Nanomaterials used in <span class="elsevierStyleItalic">Neisseria meningitidis</span> infection. A) Some of the nanoparticles used in the development of nanosensors and nanocarriers for the diagnóstico and treatment of <span class="elsevierStyleItalic">N. meningitidis</span> infection, respectively. B) Diagram of the blood–brain barrier, which the bacterium must cross in order to cause meningitis, and which nanomaterials must cross in order to treat the disease.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "I. Yañez-Sánchez, B.C. Zamarripa-Pérez, F.J. Gálvez-Gastelum" "autores" => array:3 [ 0 => array:2 [ "nombre" => "I." "apellidos" => "Yañez-Sánchez" ] 1 => array:2 [ "nombre" => "B.C." "apellidos" => "Zamarripa-Pérez" ] 2 => array:2 [ "nombre" => "F.J." "apellidos" => "Gálvez-Gastelum" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2667049621000806?idApp=UINPBA00004N" "url" => "/26670496/00000002000000S1/v4_202403290506/S2667049621000806/v4_202403290506/en/main.assets" ] "asociados" => array:1 [ 0 => array:16 [ "pii" => "S266704962400022X" "issn" => "26670496" "doi" => "10.1016/j.neurop.2024.100165" "estado" => "S100" "fechaPublicacion" => "2024-07-04" "aid" => "100165" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "err" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:8 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Erratum</span>" "titulo" => "Erratum to articles published in <span class="elsevierStyleItalic">Neurology Perspectives</span>" "subtitulo" => "Fe de errores sobre artículos publicados en la Revista Neurology Perspectives" "tienePdf" => "en" "tieneTextoCompleto" => "en" "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S266704962400022X?idApp=UINPBA00004N" "url" => "/26670496/unassign/S266704962400022X/v2_202408071214/en/main.assets" ] ] "en" => array:21 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review</span>" "titulo" => "Potential therapeutic applications of stem cell therapy for neonatal hypoxic-ischaemic brain injury" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "S49" "paginaFinal" => "S57" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "A. del Pozo, M. Villa, J. Martínez-Orgado" "autores" => array:3 [ 0 => array:4 [ "nombre" => "A." "apellidos" => "del Pozo" "email" => array:1 [ 0 => "aadelpoz@uw.edu" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "af0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cr0005" ] ] ] 1 => array:3 [ "nombre" => "M." "apellidos" => "Villa" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "af0010" ] ] ] 2 => array:3 [ "nombre" => "J." "apellidos" => "Martínez-Orgado" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "af0015" ] ] ] ] "afiliaciones" => array:3 [ 0 => array:3 [ "entidad" => "Department of Pharmacy, School of Pharmacy, University of Washington, Seattle, Washington, USA" "etiqueta" => "a" "identificador" => "af0005" ] 1 => array:3 [ "entidad" => "Biomedical Research Foundation Hospital Clinico San Carlos, Madrid, Spain" "etiqueta" => "b" "identificador" => "af0010" ] 2 => array:3 [ "entidad" => "Division of Neonatology, Hospital Clínico San Carlos - IdISSC, Madrid, Spain" "etiqueta" => "c" "identificador" => "af0015" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cr0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author at: Department of Pharmacy, 1959 NE Pacific St, Box 357630, Seattle, WA 98195, USA." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Posible aplicación terapéutica de las células madre en el daño hipóxico isquémico neonatal" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "f0010" "etiqueta" => "Fig. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 2104 "Ancho" => 3223 "Tamanyo" => 394270 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "al0010" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="sp0010" class="elsevierStyleSimplePara elsevierViewall">Therapeutic effects of stem cell therapy. Stem cell therapy administered within 24 hours of brain injury has a protective effect as it reduces astrogliosis (1) and microgliosis (2), which in turn reduces the levels of proinflammatory cytokines (3). It also prevents the increase in the levels of reactive oxygen species (4) and cell death by inhibiting caspase release (5). Stem cell therapy administered within 24 hours of the injury promotes neurorepair through cell proliferation and differentiation (6), neurogenesis (7), angiogenesis (8), and the release of trophic and anti-inflammatory factors (9). Created with BioRender.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="s0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0065">Neonatal hypoxic-ischaemic brain injury</span><p id="p0005" class="elsevierStylePara elsevierViewall">The neonatal period spans from birth to the fourth week of life.<a class="elsevierStyleCrossRefs" href="#bb0005"><span class="elsevierStyleSup">1–4</span></a> This stage, considered the most vulnerable stage of infancy, is when the risk of developing cerebral palsy (CP) is highest.<a class="elsevierStyleCrossRefs" href="#bb0005"><span class="elsevierStyleSup">1–4</span></a> CP is the most severe and most frequent form of motor disability in childhood. However, recent studies have shown that these patients frequently present other comorbidities, including hyperalgesia, cognitive impairment, and epilepsy.<a class="elsevierStyleCrossRefs" href="#bb0005"><span class="elsevierStyleSup">1–4</span></a> One of the main known causes of CP is diffuse or focal hypoxia-ischaemia.<a class="elsevierStyleCrossRefs" href="#bb0005"><span class="elsevierStyleSup">1–6</span></a></p><p id="p0010" class="elsevierStylePara elsevierViewall">Overall, nearly 2 million infants with hypoxic-ischaemic brain injury die or develop long-lasting disabling sequelae, including motor and cognitive deficits, each year; the condition greatly affects the lives of these children and their families and has a major socioeconomic impact.<a class="elsevierStyleCrossRef" href="#bb0020"><span class="elsevierStyleSup">4</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0035"><span class="elsevierStyleSup">7</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0040"><span class="elsevierStyleSup">8</span></a> Although hypoxia-ischaemia is frequent, the incidence and severity of its sequelae have not decreased over the years.<a class="elsevierStyleCrossRef" href="#bb0020"><span class="elsevierStyleSup">4</span></a> Its complex pathophysiology has hindered the development of treatments targeting all the pathogenic mechanisms simultaneously.<a class="elsevierStyleCrossRefs" href="#bb0005"><span class="elsevierStyleSup">1–4</span></a> Furthermore, the condition is usually silent; by the time it is diagnosed, it is frequently too late to act.<a class="elsevierStyleCrossRefs" href="#bb0005"><span class="elsevierStyleSup">1–4</span></a> Lastly, the currently available treatments not only have limited effectiveness and a narrow therapeutic window, but may also cause severe adverse effects that may impair the child’s development.<a class="elsevierStyleCrossRefs" href="#bb0005"><span class="elsevierStyleSup">1–4</span></a></p><p id="p0015" class="elsevierStylePara elsevierViewall">Hypoxic-ischaemic brain injury is a process caused by reduced cerebral blood flow, which leads to insufficient supply of oxygen and glucose to the brain. This causes primary energy failure and increased anaerobic metabolism, which results in increased lactate levels (increased lactic acidosis) and decreased ATP concentration (<a class="elsevierStyleCrossRef" href="#f0005">Fig. 1</a>). Blood flow, pH, and metabolite and ATP levels subsequently return to baseline levels.<a class="elsevierStyleCrossRefs" href="#bb0005"><span class="elsevierStyleSup">1–4</span></a> However, a second energy failure occurs some time later as a consequence of mitochondrial dysfunction and increased oxidative stress, inflammation, and excitotoxicity; these pathophysiological events may last several hours, and even days (<a class="elsevierStyleCrossRef" href="#f0005">Fig. 1</a>). Brain damage is caused by astrocytes and microglia. These cells release cytotoxic mediators that alter the integrity and survival of oligodendrocytes,<a class="elsevierStyleCrossRef" href="#bb0010"><span class="elsevierStyleSup">2</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0020"><span class="elsevierStyleSup">4</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0030"><span class="elsevierStyleSup">6</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRefs" href="#bb0045"><span class="elsevierStyleSup">9–12</span></a> which form myelin; myelin damage is a pathological hallmark of hypoxia-ischaemia and is responsible, at least partially, for the sequelae of CP.<a class="elsevierStyleCrossRef" href="#bb0010"><span class="elsevierStyleSup">2</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0020"><span class="elsevierStyleSup">4</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0030"><span class="elsevierStyleSup">6</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRefs" href="#bb0045"><span class="elsevierStyleSup">9–11</span></a> It is therefore essential to develop treatments able to reduce cytotoxic damage and promote oligodendrocyte survival, with the ultimate goal of preserving white matter integrity (<a class="elsevierStyleCrossRef" href="#f0005">Fig. 1</a>).</p><elsevierMultimedia ident="f0005"></elsevierMultimedia><p id="p0020" class="elsevierStylePara elsevierViewall">Besides therapeutic hypothermia, no other treatment is currently able to reduce the sequelae of hypoxia-ischaemia.<a class="elsevierStyleCrossRefs" href="#bb0005"><span class="elsevierStyleSup">1–6</span></a> Even therapeutic hypothermia has numerous disadvantages given that it only has positive effects when administered within 6 hours of the event, and only in mild cases; its therapeutic potential is therefore limited.<a class="elsevierStyleCrossRef" href="#bb0020"><span class="elsevierStyleSup">4</span></a> Other treatments with demonstrated efficacy in preclinical trials, such as erythropoietin and melatonin, have not been demonstrated to be effective in clinical practice.<a class="elsevierStyleCrossRef" href="#bb0020"><span class="elsevierStyleSup">4</span></a></p></span><span id="s0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0070">Stem cell therapy</span><p id="p0025" class="elsevierStylePara elsevierViewall">In this context, stem cell therapy has been proposed as a potential option for preventing the sequelae of neonatal hypoxia-ischaemia, as it may be used to modulate the underlying pathophysiological events and/or promote cell survival.</p><p id="p0030" class="elsevierStylePara elsevierViewall">The therapeutic use of stem cells is somewhat controversial in some cases.<a class="elsevierStyleCrossRefs" href="#bb0065"><span class="elsevierStyleSup">13–16</span></a> Such issues as the most appropriate dose, route of administration, and timing of treatment onset are still unclear.<a class="elsevierStyleCrossRefs" href="#bb0085"><span class="elsevierStyleSup">17–19</span></a> In fact, recent studies suggest that stem cells have a neuroprotective effect when treatment is started within 24 hours of hypoxic-ischaemic injury, acting against the pathophysiological processes described above.<a class="elsevierStyleCrossRef" href="#bb0085"><span class="elsevierStyleSup">17</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0100"><span class="elsevierStyleSup">20</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0105"><span class="elsevierStyleSup">21</span></a> However, when treatment is started more than 24 hours after the event, stem cells exert a neurorestorative effect, promoting neurogenesis, vasculogenesis, and brain tissue formation (<a class="elsevierStyleCrossRef" href="#f0010">Fig. 2</a>).<a class="elsevierStyleCrossRef" href="#bb0085"><span class="elsevierStyleSup">17</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0100"><span class="elsevierStyleSup">20</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0105"><span class="elsevierStyleSup">21</span></a></p><elsevierMultimedia ident="f0010"></elsevierMultimedia><p id="p0035" class="elsevierStylePara elsevierViewall">Given that the efficacy and the most appropriate route of administration and timing of treatment onset vary depending on the cell type used,<a class="elsevierStyleCrossRefs" href="#bb0085"><span class="elsevierStyleSup">17–19</span></a> we summarise the main preclinical and clinical trials conducted to date into the prevention of CP secondary to neonatal hypoxic-ischaemic brain injury by cell type.</p><span id="s0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0075">Umbilical cord blood cells</span><p id="p0040" class="elsevierStylePara elsevierViewall">For many years, umbilical cord solid tissue was treated as medical waste.<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0110"><span class="elsevierStyleSup">22</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0115"><span class="elsevierStyleSup">23</span></a> However, umbilical cord blood has recently been identified as a valuable source of stem cells and haematopoietic precursor cells.<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0110"><span class="elsevierStyleSup">22</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0115"><span class="elsevierStyleSup">23</span></a> Haematopoietic stem cells, characterised by presence of the CD34 marker, are heterogeneous cells from different lineages and at different stages of maturation that present a high capacity for self-renewal.<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0110"><span class="elsevierStyleSup">22</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0115"><span class="elsevierStyleSup">23</span></a> Furthermore, these cells, unlike other types of stem cells, are easily obtained through non-invasive means, are easy to store, and their donation poses no risk to the donor and is highly unlikely to transmit clinically relevant infections to the recipient.<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0110"><span class="elsevierStyleSup">22</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0115"><span class="elsevierStyleSup">23</span></a> Furthermore, compared to adult peripheral blood, umbilical cord blood has been found to decrease the immune response to alloantigens and rarely causes graft-versus-host disease.<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0110"><span class="elsevierStyleSup">22</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0115"><span class="elsevierStyleSup">23</span></a> However, umbilical cord blood collection should be optimised to increase the amount of cells obtained.<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0110"><span class="elsevierStyleSup">22</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0115"><span class="elsevierStyleSup">23</span></a></p><p id="p0045" class="elsevierStylePara elsevierViewall">Most preclinical studies into hypoxic-ischaemic brain injury with umbilical cord blood stem cells have used rats (<a class="elsevierStyleCrossRef" href="#t0005">Table 1</a>).<a class="elsevierStyleCrossRef" href="#bb0085"><span class="elsevierStyleSup">17</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRefs" href="#bb0120"><span class="elsevierStyleSup">24–29</span></a> These studies use the Rice-Vannucci model, in which animals undergo unilateral common carotid artery ligation and are subsequently exposed to a hypoxic environment.<a class="elsevierStyleCrossRef" href="#bb0120"><span class="elsevierStyleSup">24</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0150"><span class="elsevierStyleSup">30</span></a> In exceptional cases, these studies have also been conducted in sheep and rabbits.<a class="elsevierStyleCrossRef" href="#bb0085"><span class="elsevierStyleSup">17</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0155"><span class="elsevierStyleSup">31</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0160"><span class="elsevierStyleSup">32</span></a> Stem cells are generally administered intraperitoneally or intravenously,<a class="elsevierStyleCrossRef" href="#bb0085"><span class="elsevierStyleSup">17</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRefs" href="#bb0120"><span class="elsevierStyleSup">24–28</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0165"><span class="elsevierStyleSup">33</span></a> at a dose ranging from 10<span class="elsevierStyleSup">6</span> to 10<span class="elsevierStyleSup">7</span> cells, with no significant differences observed between doses.<a class="elsevierStyleCrossRef" href="#bb0085"><span class="elsevierStyleSup">17</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRefs" href="#bb0120"><span class="elsevierStyleSup">24–29</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0165"><span class="elsevierStyleSup">33</span></a> When treatment was started within 24 hours of hypoxic-ischaemic injury, it was shown to have a neuroprotective effect as it reduced the levels of inflammation and oxidative stress.<a class="elsevierStyleCrossRef" href="#bb0085"><span class="elsevierStyleSup">17</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0125"><span class="elsevierStyleSup">25</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0155"><span class="elsevierStyleSup">31</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0160"><span class="elsevierStyleSup">32</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0170"><span class="elsevierStyleSup">34</span></a> However, when treatment was started beyond 24 hours after injury, animals displayed fibroblast proliferation, neuronal maturation, synaptic enhancement, increased angiogenesis, and restored blood flow and blood–brain barrier permeability.<a class="elsevierStyleCrossRef" href="#bb0085"><span class="elsevierStyleSup">17</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0120"><span class="elsevierStyleSup">24</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRefs" href="#bb0130"><span class="elsevierStyleSup">26–29</span></a> Most trials were conducted at 24 hours, when a synergistic effect occurs and stem cells present both a neuroprotective effect, reducing the levels of proinflammatory cytokines, and a neurorestorative effect, promoting the maturation of neurons and neuronal synapses.<a class="elsevierStyleCrossRef" href="#bb0085"><span class="elsevierStyleSup">17</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0120"><span class="elsevierStyleSup">24</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRefs" href="#bb0130"><span class="elsevierStyleSup">26–29</span></a> This resulted in a decrease in mortality and lesion volume, with animals recovering motor and cognitive function.<a class="elsevierStyleCrossRef" href="#bb0085"><span class="elsevierStyleSup">17</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRefs" href="#bb0120"><span class="elsevierStyleSup">24–29</span></a></p><elsevierMultimedia ident="t0005"></elsevierMultimedia><p id="p0050" class="elsevierStylePara elsevierViewall">The clinical trials conducted to date have shown that infusion of autologous umbilical cord blood stem cells is safe, due to the lack of adverse reactions.<a class="elsevierStyleCrossRef" href="#bb0115"><span class="elsevierStyleSup">23</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0170"><span class="elsevierStyleSup">34</span></a> Furthermore, most treatments have been administered in several doses, starting 24 hours after hypoxic-ischaemic injury (<a class="elsevierStyleCrossRef" href="#t0010">Table 2</a>). This treatment has also been found to be safe when combined with hypothermia; however, no in vivo studies have demonstrated whether the efficacy of both treatments improves when they are administered in combination.<a class="elsevierStyleCrossRefs" href="#bb0085"><span class="elsevierStyleSup">17–19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0115"><span class="elsevierStyleSup">23</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0170"><span class="elsevierStyleSup">34</span></a></p><elsevierMultimedia ident="t0010"></elsevierMultimedia><p id="p0055" class="elsevierStylePara elsevierViewall">In conclusion, clinical and preclinical trials have shown the efficacy and safety of stem cell therapy, which constitutes a promising strategy for preventing CP, as it reduces the pathophysiological processes and promotes neuronal maturation.</p></span><span id="s0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0080">Mesenchymal stem cells</span><p id="p0060" class="elsevierStylePara elsevierViewall">As is the case with haematopoietic stem cells, mesenchymal stem cells (MSC) are undifferentiated multipotent cells that can subsequently differentiate into different lineages, including osteogenic, adipogenic, chondrogenic, and haematopoietic lineage cells.<a class="elsevierStyleCrossRefs" href="#bb0085"><span class="elsevierStyleSup">17–19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0110"><span class="elsevierStyleSup">22</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0115"><span class="elsevierStyleSup">23</span></a> However, in the context of hypoxic-ischaemic brain injury, this cell type has also been observed to differentiate into neurons.<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a> The placenta, umbilical cord tissue or blood, adipose tissue, and amniotic fluid have been identified as rich sources of MSCs.<a class="elsevierStyleCrossRefs" href="#bb0085"><span class="elsevierStyleSup">17–19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0110"><span class="elsevierStyleSup">22</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0115"><span class="elsevierStyleSup">23</span></a> Furthermore, the risk of thrombus formation or graft-versus-host disease is low, given that the cells are derived from neonatal tissue.<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a></p><p id="p0065" class="elsevierStylePara elsevierViewall">Treatment with these cells has been found to recover motor function in diseases with similar pathophysiological mechanisms (<a class="elsevierStyleCrossRef" href="#t0005">Table 1</a>).<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a> Below, we review the preclinical trials conducted to date on animal models of hypoxic-ischaemic brain injury treated with mesenchymal stem cells of different origin.</p><span id="s0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0085">Mesenchymal stem cells from umbilical cord tissue</span><p id="p0070" class="elsevierStylePara elsevierViewall">The umbilical cord (cord lining, the perivascular region, Wharton’s jelly, etc) is one of the main sources of MSCs.<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a> These cells present a high proliferation rate, express chemokines and angiogenic growth factors, secrete trophic factors, and present marked immunomodulatory activity.<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRefs" href="#bb0175"><span class="elsevierStyleSup">35–37</span></a></p><p id="p0075" class="elsevierStylePara elsevierViewall">Many preclinical trials with umbilical cord tissue–derived MSCs have used rats with hypoxic-ischaemic brain injury (Rice-Vannucci model).<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0175"><span class="elsevierStyleSup">35</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0180"><span class="elsevierStyleSup">36</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRefs" href="#bb0190"><span class="elsevierStyleSup">38–41</span></a> Rats were administered 10<span class="elsevierStyleSup">5</span> to 10<span class="elsevierStyleSup">6</span> cells<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0175"><span class="elsevierStyleSup">35</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0180"><span class="elsevierStyleSup">36</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRefs" href="#bb0190"><span class="elsevierStyleSup">38–41</span></a>; however, unlike in the case of trials of umbilical cord blood cells, these cells were most frequently administered via the intraventricular route.<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0175"><span class="elsevierStyleSup">35</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRefs" href="#bb0185"><span class="elsevierStyleSup">37–40</span></a> Furthermore, treatment was started between 1 and 5 days after injury, and cells were administered in a single dose.<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0175"><span class="elsevierStyleSup">35</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0180"><span class="elsevierStyleSup">36</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRefs" href="#bb0190"><span class="elsevierStyleSup">38–41</span></a> This treatment was found to recover motor and cognitive function, reduce brain damage, and decrease the levels of apoptotic markers due to the decrease in microgliosis and astrogliosis, and consequently in inflammation.<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0175"><span class="elsevierStyleSup">35</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0180"><span class="elsevierStyleSup">36</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRefs" href="#bb0190"><span class="elsevierStyleSup">38–41</span></a> Better results were also observed with earlier treatment onset, as this increased the release of trophic and angiogenic factors.<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRefs" href="#bb0175"><span class="elsevierStyleSup">35–37</span></a></p><p id="p0080" class="elsevierStylePara elsevierViewall">To date, umbilical cord tissue stem cells are the only MSCs that have been used in clinical trials.<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0210"><span class="elsevierStyleSup">42</span></a> A phase 1 study conducted at Duke University (NCT03635450) showed that intravenous administration of these cells was safe for children with hypoxic-ischaemic brain injury<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0210"><span class="elsevierStyleSup">42</span></a> when administered in 1 or 2 doses and at 48 hours or 2 months after injury, respectively (<a class="elsevierStyleCrossRef" href="#t0010">Table 2</a>).</p></span><span id="s0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0090">Mesenchymal stem cells from umbilical cord blood</span><p id="p0085" class="elsevierStylePara elsevierViewall">Umbilical cord blood is another source of MSCs. These multipotent cells differentiate into mesodermal, endodemal, or ectodermal lineage cells; the latter type is relevant for hypoxia-ischaemia.<a class="elsevierStyleCrossRefs" href="#bb0085"><span class="elsevierStyleSup">17–19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0110"><span class="elsevierStyleSup">22</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0115"><span class="elsevierStyleSup">23</span></a> All preclinical trials with these cells have been conducted in rats, using the Rice-Vannucci model.<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRefs" href="#bb0215"><span class="elsevierStyleSup">43–46</span></a> One study reproduces a focal hypoxic-ischaemic episode induced by middle cerebral artery occlusion.<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0220"><span class="elsevierStyleSup">44</span></a> As in the previous case, most studies used the intraventricular route, with a dose of 10<span class="elsevierStyleSup">5</span> cells.<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRefs" href="#bb0215"><span class="elsevierStyleSup">43–46</span></a> In all trials, this treatment achieved motor and cognitive function recovery by reducing lesion volume and preserving neuronal survival, decreasing levels of markers of microgliosis and astrogliosis.<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRefs" href="#bb0215"><span class="elsevierStyleSup">43–46</span></a> Furthermore, and unlike in the case of MSCs from umbilical cord tissue, these studies report that a greater number of MSCs differentiated to astrocytes and microglia, which may also contribute to the neuroprotective effects of this treatment.<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0220"><span class="elsevierStyleSup">44</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0225"><span class="elsevierStyleSup">45</span></a> It has also been reported that stem cell therapy combined with hypothermia achieves better results than either of the treatments alone, regardless of the timing of treatment onset (6-48 hours after injury).<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0215"><span class="elsevierStyleSup">43</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0230"><span class="elsevierStyleSup">46</span></a> These results show that hypothermia may enhance the neuroprotective effects of stem cell therapy and increase the window period.</p></span><span id="s0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0095">Mesenchymal stem cells from placental tissue</span><p id="p0090" class="elsevierStylePara elsevierViewall">Few studies have addressed this subject. However, 2 preclinical trials have shown that placental tissue-derived MSCs induce recovery of motor function by reducing inflammation, lipid peroxidation, and oxidative stress, and ultimately neuronal damage.<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0235"><span class="elsevierStyleSup">47</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0240"><span class="elsevierStyleSup">48</span></a> Both trials used the Rice-Vannucci rat model, and cells were administered via the intraventricular route 48 hours after injury, at a dose of 5 × 10<span class="elsevierStyleSup">4</span> and 10<span class="elsevierStyleSup">6</span> cells (<a class="elsevierStyleCrossRef" href="#t0005">Table 1</a>).<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0235"><span class="elsevierStyleSup">47</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0240"><span class="elsevierStyleSup">48</span></a></p></span><span id="s0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0100">Mesenchymal stem cells from bone marrow</span><p id="p0095" class="elsevierStylePara elsevierViewall">Bone marrow-derived MSC therapy has been one of the most frequently used approaches.<a class="elsevierStyleCrossRefs" href="#bb0245"><span class="elsevierStyleSup">49–51</span></a> However, it is no longer used due to the difficulty and low yield of obtaining these cells.<a class="elsevierStyleCrossRefs" href="#bb0245"><span class="elsevierStyleSup">49–51</span></a> In any case, studies with bone marrow-derived MSCs have provided reliable evidence of the neuroprotective capacity of these cells and their effects on hypoxic-ischaemic injury.<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRefs" href="#bb0245"><span class="elsevierStyleSup">49–51</span></a></p><p id="p0100" class="elsevierStylePara elsevierViewall">Similarly to studies into other types of MSCs, most preclinical trials into bone marrow–derived MSCs have used mice with perinatal hypoxic-ischaemic encephalopathy (Rice-Vannucci model), which were administered at doses from 10<span class="elsevierStyleSup">5</span> to 2 × 10<span class="elsevierStyleSup">6</span> cells between the first and the tenth days after injury.<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRefs" href="#bb0260"><span class="elsevierStyleSup">52–56</span></a> In most cases, cells were administered intraventricularly, as this route seems to achieve the greatest cell variability and efficacy.<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0265"><span class="elsevierStyleSup">53</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0280"><span class="elsevierStyleSup">56</span></a> In all studies, treatment with MSCs reduced lesion volume and recovered motor and cognitive function; these effects were more marked when the treatment was administered earlier, in several doses, and at larger doses.<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRefs" href="#bb0260"><span class="elsevierStyleSup">52–56</span></a> In general terms, this effect was achieved by reducing astrogliosis and microgliosis and the subsequent inflammation.<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRefs" href="#bb0260"><span class="elsevierStyleSup">52–56</span></a> Furthermore, treatment with bone marrow MSCs has been reported to achieve greater axonal function, increase the release of trophic factors, and promote the maturation and proliferation of neurons and oligodendrocytes,<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0265"><span class="elsevierStyleSup">53</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRefs" href="#bb0285"><span class="elsevierStyleSup">57–60</span></a> although differentiation into mature neurons has not been observed.<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0270"><span class="elsevierStyleSup">54</span></a> However, animals receiving MSCs combined with hypothermia presented increased infiltration of endothelial and peripheral immune cells, increased release of proinflammatory mediators, and decreased levels of trophic factors.<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0305"><span class="elsevierStyleSup">61</span></a> These results confirm the neuroprotective and neuromodulatory capacity of MSCs when not combined with hypothermia (<a class="elsevierStyleCrossRef" href="#t0005">Table 1</a>).</p><p id="p0105" class="elsevierStylePara elsevierViewall">In conclusion, MSC therapy seems to be useful for preventing hypoxic-ischaemic brain injury due to its neuroprotective properties and its ability to promote cell differentiation, proliferation, and maturation.<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRefs" href="#bb0260"><span class="elsevierStyleSup">52–60</span></a> However, the source of MSCs should be considered: while bone marrow–derived MSCs have been found to have deleterious effects when combined with hypothermia,<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0305"><span class="elsevierStyleSup">61</span></a> the combination of hypothermia and umbilical cord-derived MSC therapy seems to enhance the benefits of both treatments.<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRefs" href="#bb0215"><span class="elsevierStyleSup">43–46</span></a></p></span></span><span id="s0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0105">Endothelial progenitor cells</span><p id="p0110" class="elsevierStylePara elsevierViewall">Another approach to cell therapy uses endothelial progenitor cells from peripheral blood or bone marrow.<a class="elsevierStyleCrossRefs" href="#bb0310"><span class="elsevierStyleSup">62–67</span></a> Among many other properties, endothelial progenitor cells express CD34, CD133, and vascular endothelial growth factor receptor.<a class="elsevierStyleCrossRefs" href="#bb0310"><span class="elsevierStyleSup">62–67</span></a> These markers may play a fundamental role, since they differentially express microRNAs that are involved in the prevention of apoptosis, cytoskeleton remodelling, differentiation into multiple cell lineages, and promoting neovascularisation; this is essential for the treatment of hypoxic-ischaemic brain injury.<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRefs" href="#bb0310"><span class="elsevierStyleSup">62–67</span></a></p><p id="p0115" class="elsevierStylePara elsevierViewall">Rice-Vannucci models have shown that the administration of endothelial progenitor cells 1–2 days after injury improved motor function and decreased lesion volume.<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0140"><span class="elsevierStyleSup">28</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0180"><span class="elsevierStyleSup">36</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0340"><span class="elsevierStyleSup">68</span></a> A single dose of 10<span class="elsevierStyleSup">5</span> cells administered intraperitoneally achieved motor recovery, in part due to the release of such vasculogenic factors as fibropellin-2 precursor, vascular endothelial growth factor, and insulin-like growth factor 1<a class="elsevierStyleCrossRef" href="#bb0090"><span class="elsevierStyleSup">18</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0110"><span class="elsevierStyleSup">22</span></a> as a result of a phenotypic change to M2 microglia<a class="elsevierStyleCrossRef" href="#bb0090"><span class="elsevierStyleSup">18</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0110"><span class="elsevierStyleSup">22</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0180"><span class="elsevierStyleSup">36</span></a>; this promotes cell maturation and proliferation and regulates cerebral blood flow (<a class="elsevierStyleCrossRef" href="#t0005">Table 1</a>).<a class="elsevierStyleCrossRef" href="#bb0090"><span class="elsevierStyleSup">18</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0110"><span class="elsevierStyleSup">22</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0345"><span class="elsevierStyleSup">69</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0350"><span class="elsevierStyleSup">70</span></a></p></span><span id="s0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0110">Neural stem cells</span><p id="p0120" class="elsevierStylePara elsevierViewall">After an ischaemic event, the brain promotes the release of neuronal and glial progenitors to compensate for the neuronal and axonal loss and dysfunction.<a class="elsevierStyleCrossRef" href="#bb0030"><span class="elsevierStyleSup">6</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0090"><span class="elsevierStyleSup">18</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0355"><span class="elsevierStyleSup">71</span></a> This function is performed by neural stem cells; these self-renewing multipotent cells are able to differentiate into multiple cell lines, including neurons, astrocytes, and oligodendrocytes.<a class="elsevierStyleCrossRef" href="#bb0090"><span class="elsevierStyleSup">18</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0360"><span class="elsevierStyleSup">72</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0365"><span class="elsevierStyleSup">73</span></a> Unfortunately, the release of such proapoptotic factors as calpain and caspase 3 renders the release of neuroblasts and glial progenitors ineffective: approximately 90% of neural progenitor cells will die and the remaining 10% will not be functional.<a class="elsevierStyleCrossRef" href="#bb0090"><span class="elsevierStyleSup">18</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRefs" href="#bb0370"><span class="elsevierStyleSup">74–76</span></a> New therapies are being developed to boost self-renewal through the administration of exogenous neural stem cells.<a class="elsevierStyleCrossRef" href="#bb0090"><span class="elsevierStyleSup">18</span></a></p><p id="p0125" class="elsevierStylePara elsevierViewall">In preclinical trials, the Rice-Vannucci model is once again the most frequently used.<a class="elsevierStyleCrossRef" href="#bb0090"><span class="elsevierStyleSup">18</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRefs" href="#bb0385"><span class="elsevierStyleSup">77–83</span></a> In all cases, animals were administered either 10<span class="elsevierStyleSup">5</span> or 10<span class="elsevierStyleSup">6</span> cells, mainly via the intracranial route,<a class="elsevierStyleCrossRef" href="#bb0090"><span class="elsevierStyleSup">18</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRefs" href="#bb0385"><span class="elsevierStyleSup">77–82</span></a> although the intranasal route has also been used.<a class="elsevierStyleCrossRef" href="#bb0090"><span class="elsevierStyleSup">18</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0415"><span class="elsevierStyleSup">83</span></a> Regardless of the time of treatment onset (from 2 hours to 10 days after injury),<a class="elsevierStyleCrossRef" href="#bb0090"><span class="elsevierStyleSup">18</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRefs" href="#bb0385"><span class="elsevierStyleSup">77–83</span></a> administration of neural stem cells reduced neuroinflammation<a class="elsevierStyleCrossRef" href="#bb0090"><span class="elsevierStyleSup">18</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0390"><span class="elsevierStyleSup">78</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0405"><span class="elsevierStyleSup">81</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0415"><span class="elsevierStyleSup">83</span></a> and promoted myelination and maturation of oligodendroglial progenitor cells.<a class="elsevierStyleCrossRef" href="#bb0090"><span class="elsevierStyleSup">18</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0385"><span class="elsevierStyleSup">77</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0400"><span class="elsevierStyleSup">80</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0410"><span class="elsevierStyleSup">82</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0415"><span class="elsevierStyleSup">83</span></a> This, in turn, promoted synaptic plasticity and axonal growth, stabilised blood-brain barrier permeability, and ultimately reduced apoptosis and lesion volume in the acute and subacute phase, loss of brain tissue in the chronic phase, and motor dysfunction.<a class="elsevierStyleCrossRef" href="#bb0090"><span class="elsevierStyleSup">18</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRefs" href="#bb0385"><span class="elsevierStyleSup">77–82</span></a> Furthermore, all these benefits were observed independently of the source of the neural stem cells (embryonic tissue, fetal brain tissue, adult subventricular zone tissue, etc).<a class="elsevierStyleCrossRef" href="#bb0090"><span class="elsevierStyleSup">18</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRefs" href="#bb0385"><span class="elsevierStyleSup">77–82</span></a> However, the authors recommend starting treatment no sooner than 24 hours after injury, so that cell viability is not compromised by inflammation and excitotoxicity secondary to brain injury (<a class="elsevierStyleCrossRef" href="#t0005">Table 1</a>).<a class="elsevierStyleCrossRef" href="#bb0090"><span class="elsevierStyleSup">18</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0390"><span class="elsevierStyleSup">78</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0395"><span class="elsevierStyleSup">79</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bb0415"><span class="elsevierStyleSup">83</span></a></p><p id="p0130" class="elsevierStylePara elsevierViewall">In addition to its efficacy, clinical trials conducted at Beijing Hospital (China) have demonstrated the safety of this treatment when administered intrathecally over 2 days in combination with hypothermia (NCT02854579). Therefore, administration of exogenous neural stem cells constitutes a potential treatment for preventing hypoxic-ischaemic brain injury (<a class="elsevierStyleCrossRef" href="#t0010">Table 2</a>).</p></span></span><span id="s0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0115">Conclusion</span><p id="p0135" class="elsevierStylePara elsevierViewall">Hypoxic-ischaemic brain injury is one of the main causes of CP, the most frequent and severe motor disability in childhood. Injury occurs during the perinatal and postnatal periods, and is characterised by increased excitotoxicity, oxidative stress, and inflammation, which ultimately cause cortical and white matter lesions. Therapeutic hypothermia is the only treatment currently approved for CP; its efficacy is limited, however. Stem cell therapy may provide new opportunities for the treatment of a wide range of disorders, including CP secondary to hypoxia-ischaemia. This treatment reduces inflammation and oxidative stress and promotes cell survival, maturation, and differentiation, which ultimately leads to recovery of motor function. Although most clinical trials have used umbilical cord blood stem cells, some trials have also been conducted with MSCs and neural stem cells, demonstrating their safety in human patients. Furthermore, stem cell therapy has been found to enhance the therapeutic effects of hypothermia. These findings suggest that stem cell therapy may constitute an efficacious strategy for reducing the severity and incidence of CP secondary to hypoxic-ischaemic brain injury.</p></span><span id="s0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0120">Author contributions</span><p id="p0140" class="elsevierStylePara elsevierViewall">MV participated in data collection. JMO participated in data collection and reviewed the manuscript. AP participated in data collection, study design, and manuscript drafting.</p></span><span id="s0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0125">Funding</span><p id="p0145" class="elsevierStylePara elsevierViewall">This study has received no funding from any public, private, or non-profit organisation.</p></span><span id="s0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0130">Conflicts of interest</span><p id="p0150" class="elsevierStylePara elsevierViewall">None.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:12 [ 0 => array:3 [ "identificador" => "xres2114652" "titulo" => "Abstract" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "as0005" "titulo" => "Introduction and objectives" ] 1 => array:2 [ "identificador" => "as0010" "titulo" => "Material and methods" ] 2 => array:2 [ "identificador" => "as0015" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "as0020" "titulo" => "Conclusion" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec1801542" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres2114653" "titulo" => "Resumen" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "as0025" "titulo" => "Introducción y Objetivos" ] 1 => array:2 [ "identificador" => "as0030" "titulo" => "Material y Métodos" ] 2 => array:2 [ "identificador" => "as0035" "titulo" => "Resultados" ] 3 => array:2 [ "identificador" => "as0040" "titulo" => "Conclusión" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec1801543" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "s0005" "titulo" => "Neonatal hypoxic-ischaemic brain injury" ] 5 => array:3 [ "identificador" => "s0010" "titulo" => "Stem cell therapy" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "s0015" "titulo" => "Umbilical cord blood cells" ] 1 => array:3 [ "identificador" => "s0020" "titulo" => "Mesenchymal stem cells" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "s0025" "titulo" => "Mesenchymal stem cells from umbilical cord tissue" ] 1 => array:2 [ "identificador" => "s0030" "titulo" => "Mesenchymal stem cells from umbilical cord blood" ] 2 => array:2 [ "identificador" => "s0035" "titulo" => "Mesenchymal stem cells from placental tissue" ] 3 => array:2 [ "identificador" => "s0040" "titulo" => "Mesenchymal stem cells from bone marrow" ] ] ] 2 => array:2 [ "identificador" => "s0045" "titulo" => "Endothelial progenitor cells" ] 3 => array:2 [ "identificador" => "s0050" "titulo" => "Neural stem cells" ] ] ] 6 => array:2 [ "identificador" => "s0055" "titulo" => "Conclusion" ] 7 => array:2 [ "identificador" => "s0060" "titulo" => "Author contributions" ] 8 => array:2 [ "identificador" => "s0065" "titulo" => "Funding" ] 9 => array:2 [ "identificador" => "s0070" "titulo" => "Conflicts of interest" ] 10 => array:2 [ "identificador" => "xack736293" "titulo" => "Acknowledgements" ] 11 => array:1 [ "titulo" => "Bibliografía" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2021-07-21" "fechaAceptado" => "2021-07-24" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1801542" "palabras" => array:5 [ 0 => "Hypoxia-ischaemia" 1 => "Stem cells" 2 => "Neuroprotection" 3 => "Brain" 4 => "Neonate" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec1801543" "palabras" => array:5 [ 0 => "Hipoxia-isquemia" 1 => "Células madre" 2 => "Neuroprotección" 3 => "Cerebro" 4 => "Neonato" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:3 [ "titulo" => "Abstract" "resumen" => "<span id="as0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0010">Introduction and objectives</span><p id="sp0030" class="elsevierStyleSimplePara elsevierViewall">Neonatal hypoxic-ischaemic brain injury is one of the main known causes of cerebral palsy, the most frequent and severe form of motor disability in childhood. Hypoxia-ischaemia induces inflammation, oxidative stress, and excitotoxicity, which ultimately compromises neuronal and oligodendroglial survival and viability. No effective treatment is currently available for the condition, and the effect of therapeutic hypothermia is very limited. Recent studies have proposed stem cell therapy as a potential strategy for preventing the condition.</p></span> <span id="as0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0015">Material and methods</span><p id="sp0035" class="elsevierStyleSimplePara elsevierViewall">Most preclinical studies have used Rice-Vannucci rodent models.</p></span> <span id="as0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0020">Results</span><p id="sp0040" class="elsevierStyleSimplePara elsevierViewall">Our results showed that, depending on the timing of treatment onset, stem cells had either neuroprotective or neurorestorative effects, and ultimately recovered motor function. Although the dosage and route of administration may vary, this therapy reduced the extent of cell damage and death by attenuating the release of cytotoxic mediators. Clinical and preclinical trials have confirmed that umbilical cord stem cells and mesenchymal stem cells present sufficient efficacy and safety to be considered a potential treatment option.</p></span> <span id="as0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0025">Conclusion</span><p id="sp0045" class="elsevierStyleSimplePara elsevierViewall">We present our findings on stem cell therapy for cerebral palsy secondary to neonatal hypoxic-ischaemic brain injury.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "as0005" "titulo" => "Introduction and objectives" ] 1 => array:2 [ "identificador" => "as0010" "titulo" => "Material and methods" ] 2 => array:2 [ "identificador" => "as0015" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "as0020" "titulo" => "Conclusion" ] ] ] "es" => array:3 [ "titulo" => "Resumen" "resumen" => "<span id="as0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0035">Introducción y Objetivos</span><p id="sp0050" class="elsevierStyleSimplePara elsevierViewall">El daño cerebral hipóxico isquémico (HI) neonatal es una de las principales causas conocidas de Parálisis Cerebral infantil (PCI), la discapacidad motora más grave y frecuente durante la infancia. Como consecuencia, se produce un aumento de la inflamación, el estrés oxidativo y la excitotoxicidad que, en última instancia, comprometerán la supervivencia y viabilidad neuronal y oligodendroglial. Hoy en día no existe una terapia eficaz que logre reducir este daño más allá de la hipotermia terapéutica, cuyo efecto es muy limitado. En este sentido, recientes estudios han propuesto la terapia con células madre como una potencial estrategia a la hora de prevenir este trastorno.</p></span> <span id="as0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0040">Material y Métodos</span><p id="sp0055" class="elsevierStyleSimplePara elsevierViewall">La mayor parte de los ensayos preclínicos se han desarrollado en roedores, siguiendo el modelo de Rice Vannucci.</p></span> <span id="as0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0045">Resultados</span><p id="sp0060" class="elsevierStyleSimplePara elsevierViewall">Los resultados demostraron que, dependiendo del momento de inicio del tratamiento, las células madre ejercieron un efecto neuroprotector y neurorreparador que última instancia recuperó la funcionalidad motora. A pesar de que la vía y la dosis administrada puede variar esta terapia ha logrado reducir el volumen de daño y la muerte celular atenuando los mediadores citotóxicos liberados. A su vez, los ensayos clínicos y preclínicos han confirmado que especialmente las células derivadas de cordón umbilical y las células mesenquimales presentan unos estándares de eficacia y seguridad que permiten postularlas como una posible terapia futura.</p></span> <span id="as0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0050">Conclusión</span><p id="sp0065" class="elsevierStyleSimplePara elsevierViewall">Este trabajo recoge los principales datos obtenidos sobre el tratamiento con células madre en la PCI secundaria al daño HI.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "as0025" "titulo" => "Introducción y Objetivos" ] 1 => array:2 [ "identificador" => "as0030" "titulo" => "Material y Métodos" ] 2 => array:2 [ "identificador" => "as0035" "titulo" => "Resultados" ] 3 => array:2 [ "identificador" => "as0040" "titulo" => "Conclusión" ] ] ] ] "apendice" => array:1 [ 0 => array:1 [ "seccion" => array:1 [ 0 => array:4 [ "apendice" => "<p id="p0160" class="elsevierStylePara elsevierViewall"><elsevierMultimedia ident="ec0005"></elsevierMultimedia></p>" "etiqueta" => "Appendix A" "titulo" => "Supplementary data" "identificador" => "s0075" ] ] ] ] "multimedia" => array:5 [ 0 => array:8 [ "identificador" => "f0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2292 "Ancho" => 3173 "Tamanyo" => 384770 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "al0005" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="sp0005" class="elsevierStyleSimplePara elsevierViewall">Pathophysiology of hypoxic-ischaemic brain injury. Neonatal hypoxic-ischaemic brain injury is characterised by axonal dysfunction resulting from damage to oligodendroglial lineage cells and ultimately to myelin. Damage is mainly caused by energy failure and the release of such cytotoxic mediators as reactive oxygen species and proinflammatory molecules through the action of astrocytes (red) and microglia (yellow). Created with BioRender.</p>" ] ] 1 => array:8 [ "identificador" => "f0010" "etiqueta" => "Fig. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 2104 "Ancho" => 3223 "Tamanyo" => 394270 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "al0010" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="sp0010" class="elsevierStyleSimplePara elsevierViewall">Therapeutic effects of stem cell therapy. Stem cell therapy administered within 24 hours of brain injury has a protective effect as it reduces astrogliosis (1) and microgliosis (2), which in turn reduces the levels of proinflammatory cytokines (3). It also prevents the increase in the levels of reactive oxygen species (4) and cell death by inhibiting caspase release (5). Stem cell therapy administered within 24 hours of the injury promotes neurorepair through cell proliferation and differentiation (6), neurogenesis (7), angiogenesis (8), and the release of trophic and anti-inflammatory factors (9). Created with BioRender.</p>" ] ] 2 => array:8 [ "identificador" => "t0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "al0015" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="sp0020" class="elsevierStyleSimplePara elsevierViewall">BM: bone marrow; d: days; ECFC: endothelial colony forming cells; EPC: endothelial progenitor cell; h: hours; IA: intraarterial; IC: intracerebral; IN: intranasal; IP: intraperitoneal; IT: intrathecal; IV: intravenous; IVT: intraventricular; IVH: intraventricular haemorrhage; MCAO: middle cerebral artery occlusion; MSC: mesencephalic stem cell; NPC: neural progenitor cell; NSC: neural stem cell; OPC: oligodendrocyte precursor cell; PT: placental tissue; PWMD: periventricular white matter damage; RV: Rice-Vannucci model; SC: subcutaneous; UCB: umbilical cord blood; UCO: umbilical cord occlusion; UCT: umbilical cord tissue; UI: uterine ischaemia; w: weeks.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Cell type (species) \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Species \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Route of administration \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">No. cells \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Treatment onset \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Model \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">UCB (human, mouse) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Rat, mouse, rabbit, sheep \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">IP, IT, IVT, IA, IN, IV \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.5 × 10<span class="elsevierStyleSup">4</span> - 10<span class="elsevierStyleSup">8</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">3 h–3 w post-injury \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">RV, UI, UCO \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">UCT MSCs \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Rat, mouse \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">IP, IVT, IN, IV \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">5 x 10<span class="elsevierStyleSup">3</span> –5 x 10<span class="elsevierStyleSup">6</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1 h–5 d post-injury \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">RV, IVH, PWMD \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">UCB MSCs \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Rat \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">IVT \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">10<span class="elsevierStyleSup">5</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">6 h–3 d post-injury \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">RV, MCAO \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">PT MSCs \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Rat \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">IVT \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">5 × 10<span class="elsevierStyleSup">4</span>–10<span class="elsevierStyleSup">6</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2 d post-injury \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">RV \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">EPCs/ECFCs \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Rat, mouse \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">IP \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">10<span class="elsevierStyleSup">5</span>–5 × 10<span class="elsevierStyleSup">5</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1–2 d post-injury \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">RV \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">NPCs \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Mouse \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">IC \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2.5 × 10<span class="elsevierStyleSup">5</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2 d post-injury \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">RV \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">NSCs (human, rat, mouse) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Rat, mouse \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">IC, IVT \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">10<span class="elsevierStyleSup">5</span>–9.6 × 10<span class="elsevierStyleSup">5</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1–10 d post-injury \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">RV \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">OPCs derived from MSCs (mouse) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Rat \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">IVT \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2.5 × 10<span class="elsevierStyleSup">5</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2 h post-injury \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">RV \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> BM MSCs (human, mouse) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Rat, mouse, lamb fetus \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">IVT, IN, IV, SC \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.8 × 10<span class="elsevierStyleSup">5</span>–6 × 10<span class="elsevierStyleSup">6</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1 h–17 d post-injury \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">RV, MCAO, UCO \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab3496910.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="sp0015" class="elsevierStyleSimplePara elsevierViewall">Main preclinical trials of stem cell therapy for neonatal hypoxic-ischaemic brain injury.</p>" ] ] 3 => array:8 [ "identificador" => "t0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "al0020" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Cell type \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Trial no. \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Treatment onset (hypothermia) \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Administration route \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Trial objective \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowgroup " rowspan="8" align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Umbilical cord blood–derived stem cells</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">NCT02455830* \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">3 doses within 72 hours (yes) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowgroup " rowspan="8" align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">IV</td><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowgroup " rowspan="4" align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">To study the viability and safety of umbilical cord blood stem cell therapy in neonates with hypoxic-ischaemic brain injury</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">NCT02256618 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">3 doses within 72 hours \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">NCT02881970 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Within 3 days (yes) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowgroup " rowspan="2" align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">NCT00593242</td><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowgroup " rowspan="2" align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">4 doses within 14 days (yes)</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowgroup " rowspan="4" align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">*: To measure the levels of inflammatory cytokines and trophic factors associated with perinatal brain injury and its repair</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">NCT03352310 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">One dose within 48 hours of birth \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">NCT02551003 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">3 doses within 72 hours (yes) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">NCT02612155 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2 doses within 48 hours (yes) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">CL2020 (from adipose tissue) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">NCT04261335 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">5-14 days after birth (yes) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">IV \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">To assess the efficacy and safety of CL2020 cells for the treatment of hypoxic-ischaemic brain injury and for infant development \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Neural progenitor cells and paracrine factors \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">NCT02854579 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">3 doses of paracrine factors at 12, 24, and 48 hours after birth, and 3 doses of neural progenitor cells at 48-72 hours, 5 days, and 10 days after birth (yes) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">IT \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">To evaluate the efficacy and safety of allogenic neural progenitor cells and paracrine factors of human mesenchymal stem cells for the treatment of hypoxic-ischaemic brain injury \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowgroup " rowspan="2" align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Human umbilical cord tissue–derived mesenchymal stem cells</td><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowgroup " rowspan="2" align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">NCT03635450</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1st dose within 48 hours of birth \t\t\t\t\t\t\n \t\t\t\t</td><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowgroup " rowspan="2" align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">IV</td><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowgroup " rowspan="2" align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">To determine the safety of single and repeated intravenous doses of human umbilical cord tissue–derived mesenchymal stem cells for hypoxic-ischaemic brain injury</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2nd dose at 2 months of birth \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab3496911.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="sp0025" class="elsevierStyleSimplePara elsevierViewall">Main clinical trials of stem cell therapy for neonatal hypoxic-ischaemic brain injury.</p>" ] ] 4 => array:7 [ "identificador" => "ec0005" "tipo" => "MULTIMEDIAECOMPONENTE" "mostrarFloat" => false "mostrarDisplay" => true "detalles" => array:1 [ 0 => array:3 [ "identificador" => "al0025" "detalle" => "Image " "rol" => "short" ] ] "Ecomponente" => array:2 [ "fichero" => "mmc1.pdf" "ficheroTamanyo" => 501617 ] "descripcion" => array:1 [ "en" => "<p id="sp0070" class="elsevierStyleSimplePara elsevierViewall">IT: intrathecal</p> <p id="sp0071" class="elsevierStyleSimplePara elsevierViewall">IV: intravenous</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "Bibliografía" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bs0005" "bibliografiaReferencia" => array:83 [ 0 => array:3 [ "identificador" => "bb0005" "etiqueta" => "1." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "M.R. Pazos" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.neuropharm.2012.05.034" "Revista" => array:6 [ "tituloSerie" => "Neuropharmacology" "fecha" => "2012" "volumen" => "63" "paginaInicial" => "776" "paginaFinal" => "783" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22659086" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bb0010" "etiqueta" => "2." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Neuroprotection by cannabidiol and hypothermia in a piglet model of newborn hypoxic-ischemic brain damage" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "L. Barata" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.neuropharm.2018.11.020" "Revista" => array:6 [ "tituloSerie" => "Neuropharmacology" "fecha" => "2019" "volumen" => "146" "paginaInicial" => "1" "paginaFinal" => "11" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30468796" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bb0015" "etiqueta" => "3." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: Role of 5HT1A and CB2 receptors" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "M.R. Pazos" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.neuropharm.2013.03.027" "Revista" => array:6 [ "tituloSerie" => "Neuropharmacology" "fecha" => "2013" "volumen" => "71" "paginaInicial" => "282" "paginaFinal" => "291" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23587650" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bb0020" "etiqueta" => "4." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cannabidiol for the treatment of neonatal hypoxic-ischemic brain injury" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J. Martínez-Orgado" 1 => "M. Villa" 2 => "A. del Pozo" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Front. Pharmacol." "fecha" => "2021" "volumen" => "11" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bb0025" "etiqueta" => "5." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cannabidiol reduces brain damage and improves functional recovery in a neonatal rat model of arterial ischemic stroke" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "M. Ceprián" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.neuropharm.2016.12.017" "Revista" => array:6 [ "tituloSerie" => "Neuropharmacology" "fecha" => "2017" "volumen" => "116" "paginaInicial" => "151" "paginaFinal" => "159" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28012949" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bb0030" "etiqueta" => "6." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cannabidiol administration prevents hypoxia-ischemia-induced hypomyelination in newborn rats" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "M. Ceprián" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Front. Pharmacol." "fecha" => "2019" "volumen" => "10" ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bb0035" "etiqueta" => "7." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Neonatal IVH – mechanisms and management" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "G. Kenet" 1 => "A.A. Kuperman" 2 => "T. Strauss" 3 => "B. Brenner" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0049-3848(11)70032-9" "Revista" => array:6 [ "tituloSerie" => "Thromb. Res." "fecha" => "2011" "volumen" => "127" "paginaInicial" => "S120" "paginaFinal" => "S122" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21262430" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bb0040" "etiqueta" => "8." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Volpe’s neurology of the newborn" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "J.J. Volpe" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:1 [ "fecha" => "2008" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bb0045" "etiqueta" => "9." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "AMPA-kainate receptor inhibition promotes neurologic recovery in premature rabbits with intraventricular hemorrhage" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "P. Dohare" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1523/JNEUROSCI.4329-15.2016" "Revista" => array:6 [ "tituloSerie" => "J. Neurosci." "fecha" => "2016" "volumen" => "36" "paginaInicial" => "3363" "paginaFinal" => "3377" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26985043" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bb0050" "etiqueta" => "10." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Models of white matter injury: Comparison of infectious, hypoxic-Ischemic, and excitotoxic insults" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "H. Hagberg" 1 => "D. Peebles" 2 => "C. Mallard" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Mental Retard. Dev. Disab. Res. Rev." "fecha" => "2002" "volumen" => "8" "paginaInicial" => "30" "paginaFinal" => "38" ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bb0055" "etiqueta" => "11." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intraventricular hemorrhage and white matter injury in preclinical and clinical studies" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "O. Romantsik" 1 => "M. Bruschettini" 2 => "D. Ley" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1542/neo.20-11-e636" "Revista" => array:6 [ "tituloSerie" => "Neoreviews" "fecha" => "2019" "volumen" => "20" "paginaInicial" => "e636" "paginaFinal" => "e652" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31676738" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bb0060" "etiqueta" => "12." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Alcohol binge disrupts the rat intestinal barrier: the partial protective role of oleoylethanolamide" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "M. Antón" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/bph.14501" "Revista" => array:6 [ "tituloSerie" => "Br. J. Pharmacol." "fecha" => "2018" "volumen" => "175" "paginaInicial" => "4464" "paginaFinal" => "4479" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30248186" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bb0065" "etiqueta" => "13." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "An introduction to stem cells" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "C.S. Foster" 1 => "A. Dodson" 2 => "V. Karavana" 3 => "P.H. Smith" 4 => "Y. Ke" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J. Pathol." "fecha" => "2002" "volumen" => "197" "paginaInicial" => "419" "paginaFinal" => "423" ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bb0070" "etiqueta" => "14." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Stem cells: classifications, controversies, and clinical applications" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "L.A. Fortier" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1532-950X.2005.00063.x" "Revista" => array:6 [ "tituloSerie" => "Vet. Surg." "fecha" => "2005" "volumen" => "34" "paginaInicial" => "415" "paginaFinal" => "423" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16266332" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bb0075" "etiqueta" => "15." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cancer stem cells: controversial or just misunderstood?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "C.T. Jordan" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.stem.2009.02.003" "Revista" => array:6 [ "tituloSerie" => "Cell Stem Cell" "fecha" => "2009" "volumen" => "4" "paginaInicial" => "203" "paginaFinal" => "205" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19265659" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bb0080" "etiqueta" => "16." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Challenges and controversies in human mesenchymal stem cell therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "B. Lukomska" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Stem Cells Int." "fecha" => "2019" "volumen" => "2019" ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bb0085" "etiqueta" => "17." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Stem cell therapy for neonatal hypoxic-ischemic encephalopathy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "G.S. Gonzales-Portillo" 1 => "S. Reyes" 2 => "D. Aguirre" 3 => "M.M. Pabon" 4 => "C.V. Borlongan" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Front. Neurol." "fecha" => "2014" "volumen" => "5 AUG" ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bb0090" "etiqueta" => "18." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Neural stem cell therapies and hypoxic-ischemic brain injury" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "L. Huang" 1 => "L. Zhang" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Prog. Neurobiol." "fecha" => "2019" "volumen" => "173" "paginaInicial" => "1" "paginaFinal" => "17" ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bb0095" "etiqueta" => "19." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Stem cell therapy for neonatal hypoxic-ischemic encephalopathy: a systematic review of preclinical studies" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "I. Serrenho" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3390/ijms22010001" "Revista" => array:6 [ "tituloSerie" => "Int. J. Mol. Sci." "fecha" => "2021" "volumen" => "22" "paginaInicial" => "1" "paginaFinal" => "29" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33374898" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bb0100" "etiqueta" => "20." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Stem cells and neurological diseases" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "D.C. Hess" 1 => "C.V. Borlongan" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:5 [ "titulo" => "Cell Proliferation" "paginaInicial" => "94" "paginaFinal" => "114" "serieVolumen" => "vol. 41" "serieFecha" => "2008" ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bb0105" "etiqueta" => "21." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cell-based therapy in ischemic stroke" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "D.C. Hess" 1 => "C.V. Borlongan" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Expert Rev. Neurotherap." "fecha" => "2008" "volumen" => "8" "paginaInicial" => "1193" "paginaFinal" => "1201" ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bb0110" "etiqueta" => "22." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Future perspectives of cell therapy for neonatal hypoxic-ischemic encephalopathy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M. Nabetani" 1 => "H. Shintaku" 2 => "T. Hamazaki" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/pr.2017.260" "Revista" => array:6 [ "tituloSerie" => "Pediat. Res." "fecha" => "2018" "volumen" => "83" "paginaInicial" => "356" "paginaFinal" => "363" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29016557" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bb0115" "etiqueta" => "23." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Autologous cord blood cell therapy for neonatal hypoxic-ischaemic encephalopathy: a pilot study for feasibility and safety" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "M. Tsuji" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/s41598-019-56847-4" "Revista" => array:6 [ "tituloSerie" => "Sci. Rep." "fecha" => "2020" "volumen" => "10" "paginaInicial" => "1" "paginaFinal" => "10" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31913322" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bb0120" "etiqueta" => "24." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Multiple doses of umbilical cord blood cells improve long-term brain injury in the neonatal rat" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "T.R. Penny" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Brain Res." "fecha" => "1746" "volumen" => "2020" ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bb0125" "etiqueta" => "25." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Human cord blood transplantation in a neonatal rat model of hypoxic-ischemic brain damage: Functional outcome related to neuroprotection in the striatum" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "P.M. Pimentel-Coelho" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1089/scd.2009.0049" "Revista" => array:6 [ "tituloSerie" => "Stem Cells Dev." "fecha" => "2010" "volumen" => "19" "paginaInicial" => "351" "paginaFinal" => "358" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19296724" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bb0130" "etiqueta" => "26." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Human umbilical cord blood cells restore brain damage induced changes in rat somatosensory cortex" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "M. Geißler" 1 => "H.R. Dinse" 2 => "S. Neuhoff" 3 => "K. Kreikemeier" 4 => "C. Meier" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "PLoS One" "fecha" => "2011" "volumen" => "6" ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bb0135" "etiqueta" => "27." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Neuroglial activation and Cx43 expression are reduced upon transplantation of human umbilical cord blood cells after perinatal hypoxic-ischemic injury" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "B. Wasielewski" 1 => "A. Jensen" 2 => "A. Roth-Härer" 3 => "R. Dermietzel" 4 => "C. Meier" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.brainres.2012.05.066" "Revista" => array:6 [ "tituloSerie" => "Brain Res." "fecha" => "2012" "volumen" => "1487" "paginaInicial" => "39" "paginaFinal" => "53" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22796290" "web" => "Medline" ] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bb0140" "etiqueta" => "28." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Long-Term recovery after endothelial colony-forming cells or human umbilical cord blood cells administration in a rat model of neonatal hypoxic-ischemic encephalopathy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "I. Grandvuillemin" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/sctm.17-0074" "Revista" => array:6 [ "tituloSerie" => "Stem Cells Transl. Med." "fecha" => "2017" "volumen" => "6" "paginaInicial" => "1987" "paginaFinal" => "1996" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28980775" "web" => "Medline" ] ] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bb0145" "etiqueta" => "29." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intra-arterial transplantation of human umbilical cord blood mononuclear cells in neonatal hypoxic-ischemic rats" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "S. Greggio" 1 => "S. De Paula" 2 => "P.N. Azevedo" 3 => "G.T. Venturin" 4 => "J.C. Dacosta" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.lfs.2013.10.017" "Revista" => array:6 [ "tituloSerie" => "Life Sci." "fecha" => "2014" "volumen" => "96" "paginaInicial" => "33" "paginaFinal" => "39" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24177600" "web" => "Medline" ] ] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bb0150" "etiqueta" => "30." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Unilateral common carotid artery ligation as a model of perinatal asphyxia: the original rice-vannucci model" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "A. Nguyen" 1 => "E.A. Armstrong" 2 => "J.Y. Yager" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/978-1-4939-2709-8_1" "LibroEditado" => array:4 [ "titulo" => "Animal Models of Neurodevelopmental Disorders" "paginaInicial" => "1" "paginaFinal" => "13" "serieFecha" => "2015" ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bb0155" "etiqueta" => "31." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cord blood mononuclear cells prevent neuronal apoptosis in response to perinatal asphyxia in the newborn lamb" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "J.D.S. Aridas" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1113/JP271104" "Revista" => array:6 [ "tituloSerie" => "J. Physiol." "fecha" => "2016" "volumen" => "594" "paginaInicial" => "1421" "paginaFinal" => "1435" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26527561" "web" => "Medline" ] ] ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bb0160" "etiqueta" => "32." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Human umbilical cord blood cells ameliorate motor deficits in rabbits in a cerebral palsy model" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "A. Drobyshevsky" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000374107" "Revista" => array:6 [ "tituloSerie" => "Dev. Neurosci." "fecha" => "2015" "volumen" => "37" "paginaInicial" => "349" "paginaFinal" => "362" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25791742" "web" => "Medline" ] ] ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bb0165" "etiqueta" => "33." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effects of human umbilical cord blood CD34 + cell transplantation in neonatal hypoxic-ischemia rat model" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "Y. Yu" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Brain Dev." "fecha" => "2019" "volumen" => "41" "paginaInicial" => "173" "paginaFinal" => "181" ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bb0170" "etiqueta" => "34." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Administration of umbilical cord blood cells transiently decreased hypoxic-ischemic brain injury in neonatal rats" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "T. Hattori" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000368396" "Revista" => array:6 [ "tituloSerie" => "Dev. Neurosci." "fecha" => "2015" "volumen" => "37" "paginaInicial" => "95" "paginaFinal" => "104" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25720519" "web" => "Medline" ] ] ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bb0175" "etiqueta" => "35." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Human umbilical cord-derived mesenchymal stem cells improve learning and memory function in hypoxic-ischemic brain-damaged rats via an IL-8-mediated secretion mechanism rather than differentiation pattern induction" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "X. Zhou" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000374040" "Revista" => array:6 [ "tituloSerie" => "Cell. Physiol. Biochem." "fecha" => "2015" "volumen" => "35" "paginaInicial" => "2383" "paginaFinal" => "2401" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25896602" "web" => "Medline" ] ] ] ] ] ] ] ] 35 => array:3 [ "identificador" => "bb0180" "etiqueta" => "36." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intranasal delivery of mesenchymal stromal cells protects against neonatal hypoxic–ischemic brain injury" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "C.A. McDonald" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Int. J. Mol. Sci." "fecha" => "2019" "volumen" => "20" ] ] ] ] ] ] 36 => array:3 [ "identificador" => "bb0185" "etiqueta" => "37." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intravenous injection of umbilical cord-derived mesenchymal stromal cells attenuates reactive gliosis and hypomyelination in a neonatal intraventricular hemorrhage model" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "T. Mukai" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.neuroscience.2017.05.006" "Revista" => array:6 [ "tituloSerie" => "Neuroscience" "fecha" => "2017" "volumen" => "355" "paginaInicial" => "175" "paginaFinal" => "187" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28504197" "web" => "Medline" ] ] ] ] ] ] ] ] 37 => array:3 [ "identificador" => "bb0190" "etiqueta" => "38." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The neuroprotective effect of mesenchymal stem cells is mediated through inhibition of apoptosis in hypoxic ischemic injury" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "F. Li" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s12519-019-00310-x" "Revista" => array:6 [ "tituloSerie" => "World J. Pediatr." "fecha" => "2020" "volumen" => "16" "paginaInicial" => "193" "paginaFinal" => "200" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31535281" "web" => "Medline" ] ] ] ] ] ] ] ] 38 => array:3 [ "identificador" => "bb0195" "etiqueta" => "39." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "hUC-MSCs exert a neuroprotective effect via anti-apoptotic mechanisms in a neonatal HIE rat model" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "J. Xu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0963689719874769" "Revista" => array:6 [ "tituloSerie" => "Cell Transplant." "fecha" => "2019" "volumen" => "28" "paginaInicial" => "1552" "paginaFinal" => "1559" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31512502" "web" => "Medline" ] ] ] ] ] ] ] ] 39 => array:3 [ "identificador" => "bb0200" "etiqueta" => "40." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Umbilical cord mesenchymal stem cells and umbilical cord blood mononuclear cells improve neonatal rat memory after hypoxia-ischemia" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "J. Zhang" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.bbr.2019.01.012" "Revista" => array:6 [ "tituloSerie" => "Behav. Brain Res." "fecha" => "2019" "volumen" => "362" "paginaInicial" => "56" "paginaFinal" => "63" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30639506" "web" => "Medline" ] ] ] ] ] ] ] ] 40 => array:3 [ "identificador" => "bb0205" "etiqueta" => "41." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Therapeutic effect of human umbilical cord mesenchymal stem cells on neonatal rat hypoxic-ischemic encephalopathy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "X. Zhang" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/jnr.23304" "Revista" => array:6 [ "tituloSerie" => "J. Neurosci. Res." "fecha" => "2014" "volumen" => "92" "paginaInicial" => "35" "paginaFinal" => "45" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24265136" "web" => "Medline" ] ] ] ] ] ] ] ] 41 => array:3 [ "identificador" => "bb0210" "etiqueta" => "42." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Stem cell therapies in cerebral palsy and autism spectrum disorder" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J.M. Sun" 1 => "J. Kurtzberg" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Dev. Med. Child Neurol." "fecha" => "2021" "volumen" => "63" "paginaInicial" => "503" "paginaFinal" => "510" ] ] ] ] ] ] 42 => array:3 [ "identificador" => "bb0215" "etiqueta" => "43." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hypothermia broadens the therapeutic time window of mesenchymal stem cell transplantation for severe neonatal hypoxic ischemic encephalopathy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "S.Y. Ahn" 1 => "Y.S. Chang" 2 => "D.K. Sung" 3 => "S.I. Sung" 4 => "W.S. Park" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/s41598-018-25902-x" "Revista" => array:5 [ "tituloSerie" => "Sci. Rep." "fecha" => "2018" "volumen" => "8" "paginaInicial" => "7665" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29769612" "web" => "Medline" ] ] ] ] ] ] ] ] 43 => array:3 [ "identificador" => "bb0220" "etiqueta" => "44." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Human umbilical cord blood-derived mesenchymal stem cell transplantation attenuates severe brain injury by permanent middle cerebral artery occlusion in newborn rats" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "E.S. Kim" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/pr.2012.71" "Revista" => array:6 [ "tituloSerie" => "Pediatr. Res." "fecha" => "2012" "volumen" => "72" "paginaInicial" => "277" "paginaFinal" => "284" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22669296" "web" => "Medline" ] ] ] ] ] ] ] ] 44 => array:3 [ "identificador" => "bb0225" "etiqueta" => "45." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intracerebral transplantation of mesenchymal stem cells derived from human umbilical cord blood alleviates hypoxic ischemic brain injury in rat neonates" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "G. Xia" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1515/jpm.2010.021" "Revista" => array:6 [ "tituloSerie" => "J. Perinat. Med." "fecha" => "2010" "volumen" => "38" "paginaInicial" => "215" "paginaFinal" => "221" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20121545" "web" => "Medline" ] ] ] ] ] ] ] ] 45 => array:3 [ "identificador" => "bb0230" "etiqueta" => "46." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hypothermia augments neuroprotective activity of mesenchymal stem cells for neonatal hypoxic-ischemic encephalopathy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "W.S. Park" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "PLoS One" "fecha" => "2015" "volumen" => "10" ] ] ] ] ] ] 46 => array:3 [ "identificador" => "bb0235" "etiqueta" => "47." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Transplantation of placenta-derived mesenchymal stem cells reduces hypoxic-ischemic brain damage in rats by ameliorating the inflammatory response" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "H. Ding" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Cell. Mol. Immunol." "fecha" => "2017" "volumen" => "14" "paginaInicial" => "693" "paginaFinal" => "701" ] ] ] ] ] ] 47 => array:3 [ "identificador" => "bb0240" "etiqueta" => "48." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Therapeutic effect of placenta-derived mesenchymal stem cells on hypoxic-ischemic brain damage in rats" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "H.F. Ding" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s12519-014-0531-8" "Revista" => array:6 [ "tituloSerie" => "World J. Pediatr." "fecha" => "2015" "volumen" => "11" "paginaInicial" => "74" "paginaFinal" => "82" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25447631" "web" => "Medline" ] ] ] ] ] ] ] ] 48 => array:3 [ "identificador" => "bb0245" "etiqueta" => "49." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mesenchymal stem cell perspective: cell biology to clinical progress" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "M.F. Pittenger" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/s41536-018-0063-2" "Revista" => array:6 [ "tituloSerie" => "npj Regen. Med." "fecha" => "2019" "volumen" => "4" "paginaInicial" => "1" "paginaFinal" => "15" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30622740" "web" => "Medline" ] ] ] ] ] ] ] ] 49 => array:3 [ "identificador" => "bb0250" "etiqueta" => "50." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The role of bone marrow mesenchymal stem cell derived extracellular vesicles (MSC-EVs) in normal and abnormal hematopoiesis and their therapeutic potential" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "A.K. Batsali" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3390/jcm9030856" "Revista" => array:5 [ "tituloSerie" => "J. Clin. Med." "fecha" => "2020" "volumen" => "9" "paginaInicial" => "856" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32245055" "web" => "Medline" ] ] ] ] ] ] ] ] 50 => array:3 [ "identificador" => "bb0255" "etiqueta" => "51." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bone marrow mesenchymal stem cells: Historical overview and concepts" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "P. Charbord" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1089/hum.2010.115" "Revista" => array:6 [ "tituloSerie" => "Human Gene Therapy" "fecha" => "2010" "volumen" => "21" "paginaInicial" => "1045" "paginaFinal" => "1056" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20565251" "web" => "Medline" ] ] ] ] ] ] ] ] 51 => array:3 [ "identificador" => "bb0260" "etiqueta" => "52." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intranasal mesenchymal stem cell treatment for neonatal brain damage: long-term cognitive and sensorimotor improvement" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "V. Donega" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "PLoS One" "fecha" => "2013" "volumen" => "8" ] ] ] ] ] ] 52 => array:3 [ "identificador" => "bb0265" "etiqueta" => "53." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mesenchymal stem cells restore cortical rewiring after neonatal ischemia in mice" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "C.T.J. Van Velthoven" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/ana.23543" "Revista" => array:6 [ "tituloSerie" => "Ann. Neurol." "fecha" => "2012" "volumen" => "71" "paginaInicial" => "785" "paginaFinal" => "796" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22718545" "web" => "Medline" ] ] ] ] ] ] ] ] 53 => array:3 [ "identificador" => "bb0270" "etiqueta" => "54." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Nasal administration of stem cells: a promising novel route to treat neonatal ischemic brain damage" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "C.T.J. Van Velthoven" 1 => "A. Kavelaars" 2 => "F. Van Bel" 3 => "C.J. Heijnen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1203/PDR.0b013e3181f1c289" "Revista" => array:6 [ "tituloSerie" => "Pediatr. Res." "fecha" => "2010" "volumen" => "68" "paginaInicial" => "419" "paginaFinal" => "422" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20639794" "web" => "Medline" ] ] ] ] ] ] ] ] 54 => array:3 [ "identificador" => "bb0275" "etiqueta" => "55." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "C.T.J. van Velthoven" 1 => "A. Kavelaars" 2 => "F. van Bel" 3 => "C.J. Heijnen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.bbi.2009.10.017" "Revista" => array:6 [ "tituloSerie" => "Brain. Behav. Immun." "fecha" => "2010" "volumen" => "24" "paginaInicial" => "387" "paginaFinal" => "393" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19883750" "web" => "Medline" ] ] ] ] ] ] ] ] 55 => array:3 [ "identificador" => "bb0280" "etiqueta" => "56." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Repeated mesenchymal stem cell treatment after neonatal hypoxia-ischemia has distinct effects on formation and maturation of new neurons and oligodendrocytes leading to restoration of damage, corticospinal motor tract activity, and sensorimotor function" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "C.T.J. Van Velthoven" 1 => "A. Kavelaars" 2 => "F. Van Bel" 3 => "C.J. Heijnen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1523/JNEUROSCI.1835-10.2010" "Revista" => array:6 [ "tituloSerie" => "J. Neurosci." "fecha" => "2010" "volumen" => "30" "paginaInicial" => "9603" "paginaFinal" => "9611" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20631189" "web" => "Medline" ] ] ] ] ] ] ] ] 56 => array:3 [ "identificador" => "bb0285" "etiqueta" => "57." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Delayed post-treatment with bone marrow-derived mesenchymal stem cells is neurorestorative of striatal medium-spiny projection neurons and improves motor function after neonatal rat hypoxia-ischemia" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "S.H. Cameron" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.mcn.2015.03.019" "Revista" => array:6 [ "tituloSerie" => "Mol. Cell. Neurosci." "fecha" => "2015" "volumen" => "68" "paginaInicial" => "56" "paginaFinal" => "72" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25828540" "web" => "Medline" ] ] ] ] ] ] ] ] 57 => array:3 [ "identificador" => "bb0290" "etiqueta" => "58." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intranasally administered mesenchymal stem cells promote a regenerative niche for repair of neonatal ischemic brain injury" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "V. Donega" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Exp. Neurol." "fecha" => "2014" "volumen" => "261" "paginaInicial" => "53" "paginaFinal" => "64" ] ] ] ] ] ] 58 => array:3 [ "identificador" => "bb0295" "etiqueta" => "59." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "C.T.J. Van Velthoven" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/STROKEAHA.111.000326" "Revista" => array:6 [ "tituloSerie" => "Stroke" "fecha" => "2013" "volumen" => "44" "paginaInicial" => "1426" "paginaFinal" => "1432" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23539530" "web" => "Medline" ] ] ] ] ] ] ] ] 59 => array:3 [ "identificador" => "bb0300" "etiqueta" => "60." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mesenchymal stem cells induce T-cell tolerance and protect the preterm brain after global hypoxia-ischemia" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "R.K. Jellema" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "PLoS One" "fecha" => "2013" "volumen" => "8" ] ] ] ] ] ] 60 => array:3 [ "identificador" => "bb0305" "etiqueta" => "61." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Interaction between hypothermia and delayed mesenchymal stem cell therapy in neonatal hypoxic-ischemic brain injury" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "J. Herz" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.bbi.2018.02.006" "Revista" => array:6 [ "tituloSerie" => "Brain. Behav. Immun." "fecha" => "2018" "volumen" => "70" "paginaInicial" => "118" "paginaFinal" => "130" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29454023" "web" => "Medline" ] ] ] ] ] ] ] ] 61 => array:3 [ "identificador" => "bb0310" "etiqueta" => "62." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Challenges for heart disease stem cell therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J. Hoover-Plow" 1 => "Y. Gong" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Vasc. Health Risk Manage." "fecha" => "2012" "volumen" => "8" "paginaInicial" => "99" "paginaFinal" => "113" ] ] ] ] ] ] 62 => array:3 [ "identificador" => "bb0315" "etiqueta" => "63." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Endothelial progenitor cells in cardiovascular diseases: from biomarker to therapeutic agent" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ 0 => "H.-B. Liu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/2050-490X-1-9" "Revista" => array:5 [ "tituloSerie" => "Regen. Med. Res." "fecha" => "2013" "volumen" => "1" "paginaInicial" => "9" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25984328" "web" => "Medline" ] ] ] ] ] ] ] ] 63 => array:3 [ "identificador" => "bb0320" "etiqueta" => "64." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The role of circulating endothelial progenitor cells in tumor angiogenesis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A. Mund" 1 => "J. Case" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2174/157488811795495468" "Revista" => array:6 [ "tituloSerie" => "Curr. Stem Cell Res. Ther." "fecha" => "2011" "volumen" => "6" "paginaInicial" => "115" "paginaFinal" => "121" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21190536" …1 ] ] ] ] ] ] ] ] 64 => array:3 [ "identificador" => "bb0325" "etiqueta" => "65." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Identification of endothelial cells and progenitor cell subsets in human peripheral blood" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Curr. Prot. Cytom." "fecha" => "2010" "volumen" => "52" "paginaInicial" => "9.33.1" "paginaFinal" => "9.33.11" ] ] ] ] ] ] 65 => array:3 [ "identificador" => "bb0330" "etiqueta" => "66." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Circul. Res." "fecha" => "2012" "volumen" => "110" "paginaInicial" => "624" "paginaFinal" => "637" ] ] ] ] ] ] 66 => array:3 [ "identificador" => "bb0335" "etiqueta" => "67." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Combined characterization of microRNA and mRNA profiles delineates early differentiation pathways of CD133<span class="elsevierStyleHsp" style=""></span>+ and CD34<span class="elsevierStyleHsp" style=""></span>+ hematopoietic stem and progenitor cells" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ …1] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/stem.627" "Revista" => array:6 [ "tituloSerie" => "Stem Cells" "fecha" => "2011" "volumen" => "29" "paginaInicial" => "847" "paginaFinal" => "857" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 67 => array:3 [ "identificador" => "bb0340" "etiqueta" => "68." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The therapeutic effect of CD133<span class="elsevierStyleHsp" style=""></span>+ cells derived from human umbilical cord blood on neonatal mouse hypoxic-ischemic encephalopathy model" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ …1] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.lfs.2016.06.004" "Revista" => array:6 [ "tituloSerie" => "Life Sci." "fecha" => "2016" "volumen" => "157" "paginaInicial" => "108" "paginaFinal" => "115" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 68 => array:3 [ "identificador" => "bb0345" "etiqueta" => "69." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ …1] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/s0092-8674(02)00862-0" "Revista" => array:6 [ "tituloSerie" => "Cell" "fecha" => "2002" "volumen" => "110" "paginaInicial" => "429" "paginaFinal" => "441" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 69 => array:3 [ "identificador" => "bb0350" "etiqueta" => "70." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fibroblast growth factor-mediated proliferation of central nervous system precursors depends on endogenous production of insulin-like growth factor I" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1073/pnas.88.6.2199" "Revista" => array:6 [ "tituloSerie" => "Proc. Natl. Acad. Sci. U. S. A." "fecha" => "1991" "volumen" => "88" "paginaInicial" => "2199" "paginaFinal" => "2203" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 70 => array:3 [ "identificador" => "bb0355" "etiqueta" => "71." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Endogenous neurogenesis following ischaemic brain injury: Insights for therapeutic strategies" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.biocel.2014.08.003" "Revista" => array:6 [ "tituloSerie" => "Int. J. Biochem. Cell Biol." "fecha" => "2014" "volumen" => "56" "paginaInicial" => "4" "paginaFinal" => "19" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 71 => array:3 [ "identificador" => "bb0360" "etiqueta" => "72." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Neural precursor cells division and migration in neonatal rat brain after ischemic/hypoxic injury" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ …1] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Brain Res." "fecha" => "2005" "volumen" => "1038" "paginaInicial" => "41" "paginaFinal" => "49" ] ] ] ] ] ] 72 => array:3 [ "identificador" => "bb0365" "etiqueta" => "73." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Neurons arise in the basal neuroepithelium of the early mammalian telencephalon: a major site of neurogenesis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Proc. Natl. Acad. Sci. U. S. A." "fecha" => "2004" "volumen" => "101" "paginaInicial" => "3196" "paginaFinal" => "3201" ] ] ] ] ] ] 73 => array:3 [ "identificador" => "bb0370" "etiqueta" => "74." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Death effector activation in the subventricular zone subsequent to perinatal hypoxia/ischemia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J. Neurochem." "fecha" => "2007" "volumen" => "103" "paginaInicial" => "1121" "paginaFinal" => "1131" ] ] ] ] ] ] 74 => array:3 [ "identificador" => "bb0375" "etiqueta" => "75." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Neural stem cells in the subventricular zone are resilient to hypoxia/ischemia whereas progenitors are vulnerable" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/01.WCB.0000123906.17746.00" "Revista" => array:6 [ "tituloSerie" => "J. Cereb. Blood Flow Metab." "fecha" => "2004" "volumen" => "24" "paginaInicial" => "814" "paginaFinal" => "825" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 75 => array:3 [ "identificador" => "bb0380" "etiqueta" => "76." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hypoxia/ischemia depletes the rat perinatal subventricular zone of oligodendrocyte progenitors and neural stem cells" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ …1] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000046149" "Revista" => array:6 [ "tituloSerie" => "Dev. Neurosci." "fecha" => "2001" "volumen" => "23" "paginaInicial" => "234" "paginaFinal" => "247" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 76 => array:3 [ "identificador" => "bb0385" "etiqueta" => "77." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Long-term magnetic resonance imaging of stem cells in neonatal ischemic injury" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ …1] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Ann. Neurol." "fecha" => "2011" "volumen" => "69" "paginaInicial" => "282" "paginaFinal" => "291" ] ] ] ] ] ] 77 => array:3 [ "identificador" => "bb0390" "etiqueta" => "78." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Reduction of brain injury in neonatal hypoxic-ischemic rats by intracerebroventricular injection of neural stem/progenitor cells together with chondroitinase ABC" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ …1] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/1933719108317299" "Revista" => array:6 [ "tituloSerie" => "Reprod. Sci." "fecha" => "2008" "volumen" => "15" "paginaInicial" => "613" "paginaFinal" => "620" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 78 => array:3 [ "identificador" => "bb0395" "etiqueta" => "79." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Human neural stem cell grafts modify microglial response and enhance axonal sprouting in neonatal hypoxic-ischemic brain injury" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ …1] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/STROKEAHA.109.573691" "Revista" => array:6 [ "tituloSerie" => "Stroke" "fecha" => "2010" "volumen" => "41" "paginaInicial" => "516" "paginaFinal" => "523" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 79 => array:3 [ "identificador" => "bb0400" "etiqueta" => "80." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "rong <span class="elsevierStyleItalic">et al.</span> Neuroprotection of VEGF-expression neural stem cells in neonatal cerebral palsy rats" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ …1] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.bbr.2012.01.026" "Revista" => array:6 [ "tituloSerie" => "Behav. Brain Res." "fecha" => "2012" "volumen" => "230" "paginaInicial" => "108" "paginaFinal" => "115" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 80 => array:3 [ "identificador" => "bb0405" "etiqueta" => "81." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Delayed administration of neural stem cells after hypoxia-ischemia reduces sensorimotor deficits, cerebral lesion size, and neuroinflammation in neonatal mice" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/pr.2016.172" "Revista" => array:6 [ "tituloSerie" => "Pediatr. Res." "fecha" => "2017" "volumen" => "81" "paginaInicial" => "127" "paginaFinal" => "135" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 81 => array:3 [ "identificador" => "bb0410" "etiqueta" => "82." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cortical region-specific engraftment of embryonic stem cell-derived neural progenitor cells restores axonal sprouting to a subcortical target and achieves motor functional recovery in a mouse model of neonatal hypoxic-ischemic brain injury" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ …1] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Front. Cell. Neurosci." "fecha" => "2013" "volumen" => "7" ] ] ] ] ] ] 82 => array:3 [ "identificador" => "bb0415" "etiqueta" => "83." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "NF-κB signaling is involved in the effects of intranasally engrafted human neural stem cells on neurofunctional improvements in neonatal rat hypoxic-ischemic encephalopathy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:1 [ …1] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/cns.12441" "Revista" => array:6 [ "tituloSerie" => "CNS Neurosci. Ther." "fecha" => "2015" "volumen" => "21" "paginaInicial" => "926" "paginaFinal" => "935" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] ] ] ] ] "agradecimientos" => array:1 [ 0 => array:4 [ "identificador" => "xack736293" "titulo" => "Acknowledgements" "texto" => "<p id="p0155" class="elsevierStylePara elsevierViewall">We wish to thank BioRender for the images provided.</p>" "vista" => "all" ] ] ] "idiomaDefecto" => "en" "url" => "/26670496/00000002000000S1/v4_202403290506/S2667049621000582/v4_202403290506/en/main.assets" "Apartado" => array:4 [ "identificador" => "91829" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Review" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/26670496/00000002000000S1/v4_202403290506/S2667049621000582/v4_202403290506/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2667049621000582?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 October | 34 | 8 | 42 |
2024 September | 68 | 8 | 76 |
2024 August | 73 | 12 | 85 |
2024 July | 52 | 9 | 61 |
2024 June | 65 | 4 | 69 |
2024 May | 78 | 11 | 89 |
2024 April | 59 | 9 | 68 |
2024 March | 116 | 11 | 127 |
2024 February | 126 | 11 | 137 |
2024 January | 117 | 6 | 123 |
2023 December | 76 | 8 | 84 |
2023 November | 95 | 22 | 117 |
2023 October | 109 | 9 | 118 |
2023 September | 70 | 12 | 82 |
2023 August | 29 | 2 | 31 |
2023 July | 11 | 5 | 16 |
2023 June | 18 | 3 | 21 |
2023 May | 31 | 6 | 37 |
2023 April | 41 | 1 | 42 |
2023 March | 25 | 7 | 32 |
2023 February | 18 | 1 | 19 |
2023 January | 13 | 0 | 13 |
2022 December | 8 | 5 | 13 |
2022 November | 10 | 5 | 15 |
2022 October | 4 | 6 | 10 |
2022 September | 6 | 6 | 12 |
2022 August | 11 | 7 | 18 |
2022 July | 6 | 6 | 12 |
2022 June | 7 | 8 | 15 |
2022 May | 7 | 3 | 10 |
2022 April | 11 | 10 | 21 |
2022 March | 10 | 7 | 17 |
2022 February | 14 | 7 | 21 |
2022 January | 7 | 4 | 11 |